Maria Paola Trotta

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, P. Narciso, 2004, The Journal of infectious diseases.

Patient-reported and physician-estimated adherence to HAART

Albert W. Wu, Rita Murri, A. Wu, 2004, Journal of General Internal Medicine.

Construction, Training and Clinical Validation of An Interpretation System for Genotypic HIV-1 Drug Resistance Based on Fuzzy Rules Revised by Virological Outcomes

Marilena Vendittelli, Giovanni Ulivi, Francesco Baldini, 2003, Antiviral therapy.

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Valentina Svicher, Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, 2005, Antimicrobial Agents and Chemotherapy.

Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy.

R. Maserati, G. d’Ettorre, A. Antinori, 2011, Journal of acquired immune deficiency syndromes.

Drug-Class-Wide Resistance to Antiretrovirals in HIV-Infected Patients Failing Therapy: Prevalence, Risk Factors and Virological Outcome

P. Narciso, A. Antinori, V. Tozzi, 2005, Antiviral therapy.

Antiviral Efficacy and Genotypic Resistance Patterns of Combination Therapy with Stavudine/Tenofovir in Highly Active Antiretroviral Therapy Experienced Patients

Stefano Bonora, Stefania Merli, Massimo Andreoni, 2006, Antiviral therapy.